• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Does Pooling Make Sense?


The Enhancing Oncology Model allows pooling of groups of practices for quality measurement, which was not permitted under the OCM.

Moderator Stuart Staggs, MSIE, senior director, strategic programs, The US Oncology Network, and our panelists discuss a provision of the Enhancing Oncology Model (EOM) which would allow pooling of smaller practices into a larger group for quality measurement purposes. Not everyone thinks it's great idea. Panelists Stephen Schleicher, MD, MBA, chief medical officer, Tennessee Oncology, Kashyap Patel, MD, CEO, Carolina Blood and Cancer Care Associates and Community Oncology Alliance president, and Fred Divers, MD, chief medical officer, American Oncology Network and medical oncologist, Genesis Cancer and Blood Institute of Arkansas, discuss the concept.

Related Videos
Video 2 - "Payer Needs and Strategies for Evaluating and Covering PDTs"
Video 1 - "Differentiating PDTs from Wellness Apps and Evaluating Efficacy"
Video 4 - "Oral SERDs in Development for ER+/HER2- Metastatic Breast Cancer"
Video 3 - "The Role of Oral SERDs in ER+/HER2- Metastatic Breast Cancer"
"Integrating New PAH Therapies into Clinical Practice"
Julie Patterson, PharmD, PhD
"Clinical Evidence for Emerging PAH Therapies"
Neil Goldfarb, CEO, Greater Philadelphia Business Coalition on Health
Screenshot of Fran Gregory, PharmD, MBA, during a video interview
Video 13 - "Individualized Therapy for Specific Infections Associated with Bronchiectasis"
Related Content
© 2024 MJH Life Sciences
All rights reserved.